Cytodyn Inc (CYDY)

[buckysherm]

Thank you 5Top very much for presenting this model from which we can adjust to make our own guesses.

$20 Bill HIV revenue (I like round numbers; easy to calculate)
70% CR5 and 50% market share produces $7 Bill/ year in revenue by several years from now.

4 times sales for a buyout = $28 Bill

$100 Mill for future trial costs (conservative round number)
$100 / $1.66 = 60 Mill new shares plus 40 Mill for options and warrants = 100 Mill
200 Mill shares now + 100 Mill = 300 Mill O/S

$28 Bill / 300 Mill = ..... $93 / share.
(Throw in Europe 2/3 of US market ?) for .... $150 ish.

Caution : this is a *wildest dreams* scenario assuming approval for mono and combo therapy and general acceptance of whichever is approved first. So this wouldn't be until early 2018.

Big Pharma would be stupid to let this happen and Gilead would be INCREDIBLY stupid to let this happen. I continue to be astonished that there is no $500 Mill buyout now or more realistically, a few months after June 20.